Compare Definium Therapeutics Inc. Common Shares (DFTX) vs iShares Self-Driving EV and Tech (IDRV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs iShares Self-Driving EV and Tech — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.22 (market cap $4.59B), while iShares Self-Driving EV and Tech trades at $33.26 (market cap $264.50M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 17.4× iShares Self-Driving EV and Tech's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and iShares Self-Driving EV and Tech for 73 Days on average.
| DFTX | IDRV | |
|---|---|---|
Market Cap | $4.59B | $264.50M |
Volume | 2,103,937 | 48,021 |
Sector | Health | Sector/Thematic |
52-Week High | $48.45 | $45.48 |
52-Week Low | $10.68 | $32.68 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $3.55B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About iShares Self-Driving EV and Tech
IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →
